Xla Wt + myod1 MO has 16 phenotype(s)
Page: 1 2 ???pagination.result.next???
Images Sources Experiment + Assay Phenotypes Human Diseases
fig.4.a

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount esr1.L expression in mesoderm
fig.4.b

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount esr2.L expression in mesoderm
fig.4.c

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount foxc1.S expression in mesoderm
fig.4.d

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount msgn1.L expression in mesoderm
fig.4.e

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount myf5.L expression in mesoderm
fig.4.f

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount rbm24.L expression in mesoderm
fig.4.g

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount tbx6.L expression in mesoderm
fig.7.a

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount tbx6.L expression in mesoderm
fig.7.d

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF11.5 (in situ hybridization)
Expression Phenotype
decreased amount msgn1.L expression in mesoderm
fig.7.i, j

Maguire RJ et al. (2012) 		Xla Wt + myod1 MO

NF13 (in situ hybridization)
Expression Phenotype
decreased amount dlc.L expression in paraxial mesoderm